Prospective, Randomized, Double-blind Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients.
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2015
At a glance
- Drugs Desmopressin (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- 21 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 21 Mar 2012 Actual initiation date (Mar 2012) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 New trial record